Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



DeVinney Erick Wayne Create: Alert

All | News | Filings
Date FiledTypeDescription
03/20/2023 4 DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.
Txns: Paid exercise price by delivering 1,835 shares @ $8.27, valued at $15.2k
Paid exercise price by delivering 934 shares @ $8.27, valued at $7.7k
Exercised 5,900 restricted stock units @ $0
Exercised 3,000 restricted stock units @ $0
Granted 64,000 options to buy @ $8.27, valued at $529.3k
Granted 46,300 restricted stock units @ $0
12/29/2022 4 DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.
Txns: Paid exercise price by delivering 187 shares @ $9.44, valued at $1.8k
Exercised 750 restricted stock units @ $0
12/28/2022 4 DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.
Txns: Paid exercise price by delivering 10,784 shares @ $9.44, valued at $101.8k
Exercised 20,000 options to buy @ $5.09, valued at $101.8k
07/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2022 4 DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.
Txns: Granted 1,181 shares @ $0
Paid exercise price by delivering 357 shares @ $8.42, valued at $3k
12/29/2021 4 DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.
Txns: Paid exercise price by delivering 187 shares @ $9.74, valued at $1.8k
Exercised 750 restricted stock units @ $0
12/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2021 4 DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.
Txns: Granted 1,580 shares @ $0
Paid exercise price by delivering 392 shares @ $19.2, valued at $7.5k
04/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2020 4 DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.
Txns: Granted 1,500 shares @ $0
Sold 371 shares @ $17.81, valued at $6.6k
12/22/2020 4 DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.
Txns: Granted 575 shares @ $0
Sold 147 shares @ $16.42, valued at $2.4k
12/17/2020 4 DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.
Txns: Paid exercise price by delivering 4,373 shares @ $16.5, valued at $72.2k
Exercised 15,000 options to buy @ $4.81, valued at $72.2k
04/29/2020 4 DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.
Txns: Exercised 2,530 options to buy @ $0.27, valued at $683.1
03/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/31/2018 4 DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.
Txns: Granted 11,900 options to buy @ $19.17, valued at $228.1k
Granted 3,000 restricted stock units @ $0
11/15/2018 4 DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.
Txns: Paid exercise price by delivering 2,882 shares @ $33.28, valued at $95.9k
Exercised 35,000 options to buy @ $2.74, valued at $95.9k
Exercised 274 options to buy @ $0.27, valued at $74
12/20/2017 4 DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.
Txns: Granted 13,900 options to buy @ $27, valued at $375.3k
Granted 2,300 restricted stock units @ $0
03/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/31/2016 4/A DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.
Txns: Granted 20,000 options to buy @ $5.09, valued at $101.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy